Organization
General Hospital of Ningxia Medical University
20 clinical trials
3 abstracts
Clinical trial
Comparison of Different 6% Hydroxyethyl Starch (130/0.4) Coload Volumes on the 90% Effective Dose of Norepinephrine Infusion Prophylaxis for Hypotension During Spinal Anesthesia for Cesarean SectionStatus: Completed, Estimated PCD: 2024-01-23
Clinical trial
6% Hydroxyethyl Starch (130/0.4) Coload for Postspinal Anesthesia Hypotension in Patients Undergoing Caesarean Section: A Randomized Sequential Allocation Dose-finding StudyStatus: Recruiting, Estimated PCD: 2024-04-21
Abstract
Nimotuzumab in combination with radiotherapy for elderly patients with locally advanced cervical squamous cell carcinoma: Results from a prospective, multicenter, open-label, single-arm trial.Org: Zhangzhou Hospital Affiliated to Fujian Medical University, The First Affiliated Hospital of Xi’an Jiaotong University, Henan Cancer Hospital/Affiliated Cancer Hospital of Zhengzhou University, Yantai Yuhunagding Hospital, The Affiliated Hospital of Southwest Medical University,
Clinical trial
90% Effective Dose of Norepinephrine Infusions for Preventing Postspinal Anesthesia Hypotension Under Intensive and Standard Treatment in Preeclamptic Patients During Cesarean SectionStatus: Not yet recruiting, Estimated PCD: 2025-06-30
Clinical trial
90% Effective Dose of Phenylephrine Infusions for Preventing Postspinal Anesthesia Hypotension Under Intensive and Standard Treatment During Cesarean SectionStatus: Not yet recruiting, Estimated PCD: 2025-06-30
Clinical trial
Maternal Cardiac Output Response to Rescue Norepinephrine and Phenylephrine Boluses During Spinal Anesthesia for Caesarean Section in Patients With Severe Preeclampsia: a Randomized, Controlled TrialStatus: Completed, Estimated PCD: 2024-01-21
Clinical trial
ED90 of Norepinephrine and Phenylephrine Infusions for Preventing Postspinal Anesthesia Hypotension Under Intensive Treatment in Preeclamptic Patients During Cesarean SectionStatus: Not yet recruiting, Estimated PCD: 2025-06-30
Clinical trial
Comparison of Prophylactic Norepinephrine and Phenylephrine Infusion for Hemodynamic Effects in Patients With Preeclampsia During Cesarean Section: a Randomized, Controlled TrialStatus: Recruiting, Estimated PCD: 2025-04-21
Clinical trial
Intensive Versus Standard Treatment for Spinal Anesthesia-induced Hypotension on Neonatal Outcomes in Preeclamptic Patients During Cesarean SectionStatus: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
Intensive Versus Standard Treatment for Spinal Anesthesia-induced Hypotension on Maternal Hemodynamics in Preeclamptic Patients During Cesarean SectionStatus: Not yet recruiting, Estimated PCD: 2024-12-31
Clinical trial
Ondansetron for Postspinal Anesthesia Hypotension in Patients Undergoing Cesarean Section: A Randomized, Controlled TrialStatus: Completed, Estimated PCD: 2023-10-27
Clinical trial
The Effect of Low-dose Ketamine on Postoperative Pain Relief and Sleep Quality in Patients Undergoing Laparoscopic Uterine SurgeryStatus: Recruiting, Estimated PCD: 2024-10-01
Clinical trial
Intensive Versus Standard Treatment for Spinal Anesthesia-induced Hypotension on Maternal Hemodynamics During Cesarean Section: A Multicenter, Prospective, Single-blind, Randomized, Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2025-12-31
Clinical trial
ED90 of Norepinephrine and Phenylephrine Boluses for Treating Postspinal Anesthesia Hypotension Under Intensive Treatment in Preeclamptic Patients During Cesarean SectionStatus: Not yet recruiting, Estimated PCD: 2025-12-30
Clinical trial
ED90 of Norepinephrine and Phenylephrine Infusions for Preventing Postspinal Anesthesia Hypotension Under Intensive Treatment During Cesarean SectionStatus: Not yet recruiting, Estimated PCD: 2025-03-30
Clinical trial
90% Effective Dose of Norepinephrine Infusions for Preventing Postspinal Anesthesia Hypotension Under Intensive and Standard Treatment During Cesarean SectionStatus: Not yet recruiting, Estimated PCD: 2025-03-31
Clinical trial
ED90 of Norepinephrine and Phenylephrine Boluses for Treating Postspinal Anesthesia Hypotension Under Intensive Treatment During Cesarean SectionStatus: Not yet recruiting, Estimated PCD: 2025-06-30
Clinical trial
90% Effective Dose of Phenylephrine Infusions for Preventing Postspinal Anesthesia Hypotension Under Intensive and Standard Treatment in Preeclamptic Patients During Cesarean SectionStatus: Not yet recruiting, Estimated PCD: 2025-12-31
Clinical trial
Comparison of 6% Hydroxyethyl Starch (130/0.4) and Crystalloid Coload Combined With Prophylactic Norepinephrine Infusion for Postspinal Anesthesia Hypotension in Patients Undergoing Caesarean SectionStatus: Completed, Estimated PCD: 2023-03-21
Clinical trial
Up-and-Down Determination of Different Crystalloid Coload Volumes on the 90% Effective Dose of Prophylactic Norepinephrine Infusions for Preventing Postspinal Anesthesia Hypotension During Cesarean SectionStatus: Completed, Estimated PCD: 2023-06-16
Clinical trial
Norepinephrine Prophylaxis for Postspinal Anesthesia Hypotension in Parturients With Preeclampsia Undergoing Cesarean Section: a Randomized, Placebo-controlled Dose-finding TrialStatus: Completed, Estimated PCD: 2023-06-06
Abstract
Anti-HER2 antibody inetetamab plus camrelizumab and utidelone for pretreated HER2-positive metastatic breast cancer: Final results from the phase 2 ICU trial.Org: Department of Breast Disease, Henan Breast Cancer Center, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China, Henan Breast Cancer Center, Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Breast Medicine Service, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, China,
Abstract
Molecular characteristics of KRAS mutations in Chinese patients with cancer.Org: General Hospital of Ningxia Medical University, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing Simcere Medical Laboratory Science Co., Ltd., Nanjing Simcere Medical Laboratory Science Co., Ltd., The State Key Lab of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing, China,